193 related articles for article (PubMed ID: 34245091)
21. Long-Chain Non-Coding RNA Metastasis-Related Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes the Proliferation and Migration of Human Pulmonary Artery Smooth Muscle Cells (hPASMCs) by Regulating the MicroRNA-503 (miR-503)/Toll-Like Receptor 4 (TLR4) Signal Axis.
He M; Shen J; Zhang C; Chen Y; Wang W; Tao K
Med Sci Monit; 2020 Jul; 26():e923123. PubMed ID: 32712618
[TBL] [Abstract][Full Text] [Related]
22. LncRNA-Ang362 Promotes Pulmonary Arterial Hypertension by Regulating miR-221 and miR-222.
Wang H; Qin R; Cheng Y
Shock; 2020 Jun; 53(6):723-729. PubMed ID: 31313741
[TBL] [Abstract][Full Text] [Related]
23. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
24. Dissecting Molecular Mechanisms Underlying Pulmonary Vascular Smooth Muscle Cell Dedifferentiation in Pulmonary Hypertension: Role of Mutated Caveolin-1 (Cav1
Yu W; Chen H; Yang H; Ding J; Xia P; Mei X; Wang L; Chen S; Zou C; Wang LX
Heart Lung Circ; 2019 Oct; 28(10):1587-1597. PubMed ID: 30262154
[TBL] [Abstract][Full Text] [Related]
25. MiR-23a regulates the proliferation and migration of human pulmonary artery smooth muscle cells (HPASMCs) through targeting BMPR2/Smad1 signaling.
Zhang Y; Peng B; Han Y
Biomed Pharmacother; 2018 Jul; 103():1279-1286. PubMed ID: 29864909
[TBL] [Abstract][Full Text] [Related]
26. MiR-629 regulates hypoxic pulmonary vascular remodelling by targeting FOXO3 and PERP.
Zhao M; Chen N; Li X; Lin L
J Cell Mol Med; 2019 Aug; 23(8):5165-5175. PubMed ID: 31240850
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA and mRNA profile analysis of metformin to reverse the pulmonary hypertension vascular remodeling induced by monocrotaline.
Sun Z; Liu Y; Yu F; Xu Y; Yanli L; Liu N
Biomed Pharmacother; 2019 Jul; 115():108933. PubMed ID: 31060005
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of 18β-glycyrrhetinic acid on pulmonary arterial hypertension via regulation of Rho A/Rho kinsase pathway.
Zhang M; Chang Z; Zhang P; Jing Z; Yan L; Feng J; Hu Z; Xu Q; Zhou W; Ma P; Hao Y; Zhou R
Chem Biol Interact; 2019 Sep; 311():108749. PubMed ID: 31325423
[TBL] [Abstract][Full Text] [Related]
29. Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt-related pulmonary arterial hypertension.
Zhou JJ; Yang J; Li L; Quan RL; Chen XX; Qian YL; Huang L; Wang PH; Li Y; Meng XM; Chen X; Gu Q; He JG
ESC Heart Fail; 2022 Oct; 9(5):3407-3417. PubMed ID: 35841124
[TBL] [Abstract][Full Text] [Related]
30. HMGB1-induced activation of ER stress contributes to pulmonary artery hypertension in vitro and in vivo.
Zhang Q; Chen Y; Wang Q; Wang Y; Feng W; Chai L; Liu J; Li D; Chen H; Qiu Y; Shen N; Shi X; Xie X; Li M
Respir Res; 2023 Jun; 24(1):149. PubMed ID: 37268944
[TBL] [Abstract][Full Text] [Related]
31. Long non‑coding RNA MALAT1 sponges miR‑124‑3p.1/KLF5 to promote pulmonary vascular remodeling and cell cycle progression of pulmonary artery hypertension.
Wang D; Xu H; Wu B; Jiang S; Pan H; Wang R; Chen J
Int J Mol Med; 2019 Sep; 44(3):871-884. PubMed ID: 31257528
[TBL] [Abstract][Full Text] [Related]
32. Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.
Goncharov DA; Kudryashova TV; Ziai H; Ihida-Stansbury K; DeLisser H; Krymskaya VP; Tuder RM; Kawut SM; Goncharova EA
Circulation; 2014 Feb; 129(8):864-74. PubMed ID: 24270265
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
[TBL] [Abstract][Full Text] [Related]
34. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
[TBL] [Abstract][Full Text] [Related]
35. MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension.
Miao R; Liu W; Qi C; Song Y; Zhang Y; Fu Y; Liu W; Lang Y; Zhang Y; Zhang Z
Life Sci; 2020 Sep; 257():117919. PubMed ID: 32585247
[TBL] [Abstract][Full Text] [Related]
36. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
Xu Y; Sun Z; Wang Q; Wang T; Liu Y; Yu F
Vascul Pharmacol; 2019 Sep; 120():106568. PubMed ID: 31207359
[TBL] [Abstract][Full Text] [Related]
37. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
[TBL] [Abstract][Full Text] [Related]
38. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
39. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.
Chen B; Lu X; Zhou Q; Chen Q; Zhu S; Li G; Liu H
PLoS One; 2023; 18(8):e0290031. PubMed ID: 37582104
[TBL] [Abstract][Full Text] [Related]
40. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
